Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy.

Authors
Type
Published Article
Journal
Cancer Chemotherapy and Pharmacology
1432-0843
Publisher
Springer-Verlag
Publication Date
Volume
67
Issue
2
Pages
275–284
Identifiers
DOI: 10.1007/s00280-010-1315-z
PMID: 20379816
Source
Medline
License
Unknown

Abstract

Ciprofloxacin and imatinib significantly improve growth inhibition activity of standard antineoplastic drugs in a schedule-dependent manner and, therefore, may have an important role as adjuvant therapeutic agents in a clinical setting.

Statistics

Seen <100 times